NASDAQ · Biotechnology

Artelo Biosciences Inc (ARTL)

$2.22 -3.90%
Add alert See all oversold stocks →
29 Oversold Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 200$24.25-90.85%

Company profile

Artelo Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. The company is headquartered in La Jolla, California.

SectorHealthcare
IndustryBiotechnology
Market cap$1.70M
P/E ratioNone
EPS$-136.26
Beta-0.074
Dividend yield0.00%
52-week high$122.58
52-week low$2.93

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 41 VRTX Vertex Pharmaceuticals Inc RSI 68 CRSP CRISPR Therapeutics AG RSI 48 IOVA Iovance Biotherapeutics Inc RSI 30 ZVSA ZyVersa Therapeutics Inc RSI 15 VRAX Virax Biolabs Group Ltd - Class A RSI 27 GOVX Geovax Labs Inc RSI 17 SKYE Skye Bioscience Inc RSI 31 IMNN Imunon Inc RSI 36 ACXP Acurx Pharmaceuticals Inc RSI 27
30 days of PRO Unlimited free, no card

RSI alerts for ARTL

An email when ARTL closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 13 October 2026 at 10:15 PM EDT